COVID-19 Impact on Global Pediatrics Medicine Market Size, Status and Forecast 2020-2026
![](/report_cover/6975/covid-19-impact-on-global-pediatrics-medicine-market-size-status-n-forecast-2020-2026_en.gif)
This report focuses on the global Pediatrics Medicine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pediatrics Medicine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
The key players covered in this study
- GSK
- Novartis
- Pfizer
- Sanofi
- Abbott
- Bristol-Myers Squibb
- Cipla
- Eisai Pharmaceuticals
- Eli Lilly
- F. Hoffman-La Roche
- Glenmark
- Helsinn Healthcare
- Heron Therapeutics
- Ipca Laboratories
- Lupin Pharmaceuticals
- Merck Sharp & Dohme
- RedHill
- Sun Pharmaceutical Industries
- Takeda Pharmaceutical
- Enteral
- Parenteral
- Respiratory diseases
- Infectious diseases
- Gastrointestinal diseases
- CNS diseases
- Oncological diseases
- CVDs
- Others
- North America
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
- To analyze global Pediatrics Medicine status, future forecast, growth opportunity, key market and key players.
- To present the Pediatrics Medicine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by type, market and key regions.
- History Year: 2015-2019
- Base Year: 2019
- Estimated Year: 2020
- Forecast Year 2020 to 2026
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pediatrics Medicine Revenue
1.4 Market Analysis by Type
1.4.1 Global Pediatrics Medicine Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Enteral
1.4.3 Parenteral
1.5 Market by Application
1.5.1 Global Pediatrics Medicine Market Share by Application: 2020 VS 2026
1.5.2 Respiratory diseases
1.5.3 Infectious diseases
1.5.4 Gastrointestinal diseases
1.5.5 CNS diseases
1.5.6 Oncological diseases
1.5.7 CVDs
1.5.8 Others
1.6 Coronavirus Disease 2019 (Covid-19): Pediatrics Medicine Industry Impact
1.6.1 How the Covid-19 is Affecting the Pediatrics Medicine Industry
1.6.1.1 Pediatrics Medicine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Pediatrics Medicine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Pediatrics Medicine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Pediatrics Medicine Market Perspective (2015-2026)
2.2 Pediatrics Medicine Growth Trends by Regions
2.2.1 Pediatrics Medicine Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pediatrics Medicine Historic Market Share by Regions (2015-2020)
2.2.3 Pediatrics Medicine Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pediatrics Medicine Market Growth Strategy
2.3.6 Primary Interviews with Key Pediatrics Medicine Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Pediatrics Medicine Players by Market Size
3.1.1 Global Top Pediatrics Medicine Players by Revenue (2015-2020)
3.1.2 Global Pediatrics Medicine Revenue Market Share by Players (2015-2020)
3.1.3 Global Pediatrics Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pediatrics Medicine Market Concentration Ratio
3.2.1 Global Pediatrics Medicine Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pediatrics Medicine Revenue in 2019
3.3 Pediatrics Medicine Key Players Head office and Area Served
3.4 Key Players Pediatrics Medicine Product Solution and Service
3.5 Date of Enter into Pediatrics Medicine Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Pediatrics Medicine Historic Market Size by Type (2015-2020)
4.2 Global Pediatrics Medicine Forecasted Market Size by Type (2021-2026)
5 PEDIATRICS MEDICINE BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Pediatrics Medicine Market Size by Application (2015-2020)
5.2 Global Pediatrics Medicine Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Pediatrics Medicine Market Size (2015-2020)
6.2 Pediatrics Medicine Key Players in North America (2019-2020)
6.3 North America Pediatrics Medicine Market Size by Type (2015-2020)
6.4 North America Pediatrics Medicine Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Pediatrics Medicine Market Size (2015-2020)
7.2 Pediatrics Medicine Key Players in Europe (2019-2020)
7.3 Europe Pediatrics Medicine Market Size by Type (2015-2020)
7.4 Europe Pediatrics Medicine Market Size by Application (2015-2020)
8 CHINA
8.1 China Pediatrics Medicine Market Size (2015-2020)
8.2 Pediatrics Medicine Key Players in China (2019-2020)
8.3 China Pediatrics Medicine Market Size by Type (2015-2020)
8.4 China Pediatrics Medicine Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Pediatrics Medicine Market Size (2015-2020)
9.2 Pediatrics Medicine Key Players in Japan (2019-2020)
9.3 Japan Pediatrics Medicine Market Size by Type (2015-2020)
9.4 Japan Pediatrics Medicine Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Pediatrics Medicine Market Size (2015-2020)
10.2 Pediatrics Medicine Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pediatrics Medicine Market Size by Type (2015-2020)
10.4 Southeast Asia Pediatrics Medicine Market Size by Application (2015-2020)
11 INDIA
11.1 India Pediatrics Medicine Market Size (2015-2020)
11.2 Pediatrics Medicine Key Players in India (2019-2020)
11.3 India Pediatrics Medicine Market Size by Type (2015-2020)
11.4 India Pediatrics Medicine Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Pediatrics Medicine Market Size (2015-2020)
12.2 Pediatrics Medicine Key Players in Central & South America (2019-2020)
12.3 Central & South America Pediatrics Medicine Market Size by Type (2015-2020)
12.4 Central & South America Pediatrics Medicine Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 GSK
13.1.1 GSK Company Details
13.1.2 GSK Business Overview and Its Total Revenue
13.1.3 GSK Pediatrics Medicine Introduction
13.1.4 GSK Revenue in Pediatrics Medicine Business (2015-2020))
13.1.5 GSK Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview and Its Total Revenue
13.2.3 Novartis Pediatrics Medicine Introduction
13.2.4 Novartis Revenue in Pediatrics Medicine Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview and Its Total Revenue
13.3.3 Pfizer Pediatrics Medicine Introduction
13.3.4 Pfizer Revenue in Pediatrics Medicine Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Sanofi
13.4.1 Sanofi Company Details
13.4.2 Sanofi Business Overview and Its Total Revenue
13.4.3 Sanofi Pediatrics Medicine Introduction
13.4.4 Sanofi Revenue in Pediatrics Medicine Business (2015-2020)
13.4.5 Sanofi Recent Development
13.5 Abbott
13.5.1 Abbott Company Details
13.5.2 Abbott Business Overview and Its Total Revenue
13.5.3 Abbott Pediatrics Medicine Introduction
13.5.4 Abbott Revenue in Pediatrics Medicine Business (2015-2020)
13.5.5 Abbott Recent Development
13.6 Bristol-Myers Squibb
13.6.1 Bristol-Myers Squibb Company Details
13.6.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
13.6.3 Bristol-Myers Squibb Pediatrics Medicine Introduction
13.6.4 Bristol-Myers Squibb Revenue in Pediatrics Medicine Business (2015-2020)
13.6.5 Bristol-Myers Squibb Recent Development
13.7 Cipla
13.7.1 Cipla Company Details
13.7.2 Cipla Business Overview and Its Total Revenue
13.7.3 Cipla Pediatrics Medicine Introduction
13.7.4 Cipla Revenue in Pediatrics Medicine Business (2015-2020)
13.7.5 Cipla Recent Development
13.8 Eisai Pharmaceuticals
13.8.1 Eisai Pharmaceuticals Company Details
13.8.2 Eisai Pharmaceuticals Business Overview and Its Total Revenue
13.8.3 Eisai Pharmaceuticals Pediatrics Medicine Introduction
13.8.4 Eisai Pharmaceuticals Revenue in Pediatrics Medicine Business (2015-2020)
13.8.5 Eisai Pharmaceuticals Recent Development
13.9 Eli Lilly
13.9.1 Eli Lilly Company Details
13.9.2 Eli Lilly Business Overview and Its Total Revenue
13.9.3 Eli Lilly Pediatrics Medicine Introduction
13.9.4 Eli Lilly Revenue in Pediatrics Medicine Business (2015-2020)
13.9.5 Eli Lilly Recent Development
13.10 F. Hoffman-La Roche
13.10.1 F. Hoffman-La Roche Company Details
13.10.2 F. Hoffman-La Roche Business Overview and Its Total Revenue
13.10.3 F. Hoffman-La Roche Pediatrics Medicine Introduction
13.10.4 F. Hoffman-La Roche Revenue in Pediatrics Medicine Business (2015-2020)
13.10.5 F. Hoffman-La Roche Recent Development
13.11 Glenmark
10.11.1 Glenmark Company Details
10.11.2 Glenmark Business Overview and Its Total Revenue
10.11.3 Glenmark Pediatrics Medicine Introduction
10.11.4 Glenmark Revenue in Pediatrics Medicine Business (2015-2020)
10.11.5 Glenmark Recent Development
13.12 Helsinn Healthcare
10.12.1 Helsinn Healthcare Company Details
10.12.2 Helsinn Healthcare Business Overview and Its Total Revenue
10.12.3 Helsinn Healthcare Pediatrics Medicine Introduction
10.12.4 Helsinn Healthcare Revenue in Pediatrics Medicine Business (2015-2020)
10.12.5 Helsinn Healthcare Recent Development
13.13 Heron Therapeutics
10.13.1 Heron Therapeutics Company Details
10.13.2 Heron Therapeutics Business Overview and Its Total Revenue
10.13.3 Heron Therapeutics Pediatrics Medicine Introduction
10.13.4 Heron Therapeutics Revenue in Pediatrics Medicine Business (2015-2020)
10.13.5 Heron Therapeutics Recent Development
13.14 Ipca Laboratories
10.14.1 Ipca Laboratories Company Details
10.14.2 Ipca Laboratories Business Overview and Its Total Revenue
10.14.3 Ipca Laboratories Pediatrics Medicine Introduction
10.14.4 Ipca Laboratories Revenue in Pediatrics Medicine Business (2015-2020)
10.14.5 Ipca Laboratories Recent Development
13.15 Lupin Pharmaceuticals
10.15.1 Lupin Pharmaceuticals Company Details
10.15.2 Lupin Pharmaceuticals Business Overview and Its Total Revenue
10.15.3 Lupin Pharmaceuticals Pediatrics Medicine Introduction
10.15.4 Lupin Pharmaceuticals Revenue in Pediatrics Medicine Business (2015-2020)
10.15.5 Lupin Pharmaceuticals Recent Development
13.16 Merck Sharp & Dohme
10.16.1 Merck Sharp & Dohme Company Details
10.16.2 Merck Sharp & Dohme Business Overview and Its Total Revenue
10.16.3 Merck Sharp & Dohme Pediatrics Medicine Introduction
10.16.4 Merck Sharp & Dohme Revenue in Pediatrics Medicine Business (2015-2020)
10.16.5 Merck Sharp & Dohme Recent Development
13.17 RedHill
10.17.1 RedHill Company Details
10.17.2 RedHill Business Overview and Its Total Revenue
10.17.3 RedHill Pediatrics Medicine Introduction
10.17.4 RedHill Revenue in Pediatrics Medicine Business (2015-2020)
10.17.5 RedHill Recent Development
13.18 Sun Pharmaceutical Industries
10.18.1 Sun Pharmaceutical Industries Company Details
10.18.2 Sun Pharmaceutical Industries Business Overview and Its Total Revenue
10.18.3 Sun Pharmaceutical Industries Pediatrics Medicine Introduction
10.18.4 Sun Pharmaceutical Industries Revenue in Pediatrics Medicine Business (2015-2020)
10.18.5 Sun Pharmaceutical Industries Recent Development
13.19 Takeda Pharmaceutical
10.19.1 Takeda Pharmaceutical Company Details
10.19.2 Takeda Pharmaceutical Business Overview and Its Total Revenue
10.19.3 Takeda Pharmaceutical Pediatrics Medicine Introduction
10.19.4 Takeda Pharmaceutical Revenue in Pediatrics Medicine Business (2015-2020)
10.19.5 Takeda Pharmaceutical Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pediatrics Medicine Revenue
1.4 Market Analysis by Type
1.4.1 Global Pediatrics Medicine Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Enteral
1.4.3 Parenteral
1.5 Market by Application
1.5.1 Global Pediatrics Medicine Market Share by Application: 2020 VS 2026
1.5.2 Respiratory diseases
1.5.3 Infectious diseases
1.5.4 Gastrointestinal diseases
1.5.5 CNS diseases
1.5.6 Oncological diseases
1.5.7 CVDs
1.5.8 Others
1.6 Coronavirus Disease 2019 (Covid-19): Pediatrics Medicine Industry Impact
1.6.1 How the Covid-19 is Affecting the Pediatrics Medicine Industry
1.6.1.1 Pediatrics Medicine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Pediatrics Medicine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Pediatrics Medicine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Pediatrics Medicine Market Perspective (2015-2026)
2.2 Pediatrics Medicine Growth Trends by Regions
2.2.1 Pediatrics Medicine Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pediatrics Medicine Historic Market Share by Regions (2015-2020)
2.2.3 Pediatrics Medicine Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pediatrics Medicine Market Growth Strategy
2.3.6 Primary Interviews with Key Pediatrics Medicine Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Pediatrics Medicine Players by Market Size
3.1.1 Global Top Pediatrics Medicine Players by Revenue (2015-2020)
3.1.2 Global Pediatrics Medicine Revenue Market Share by Players (2015-2020)
3.1.3 Global Pediatrics Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pediatrics Medicine Market Concentration Ratio
3.2.1 Global Pediatrics Medicine Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pediatrics Medicine Revenue in 2019
3.3 Pediatrics Medicine Key Players Head office and Area Served
3.4 Key Players Pediatrics Medicine Product Solution and Service
3.5 Date of Enter into Pediatrics Medicine Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Pediatrics Medicine Historic Market Size by Type (2015-2020)
4.2 Global Pediatrics Medicine Forecasted Market Size by Type (2021-2026)
5 PEDIATRICS MEDICINE BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Pediatrics Medicine Market Size by Application (2015-2020)
5.2 Global Pediatrics Medicine Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Pediatrics Medicine Market Size (2015-2020)
6.2 Pediatrics Medicine Key Players in North America (2019-2020)
6.3 North America Pediatrics Medicine Market Size by Type (2015-2020)
6.4 North America Pediatrics Medicine Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Pediatrics Medicine Market Size (2015-2020)
7.2 Pediatrics Medicine Key Players in Europe (2019-2020)
7.3 Europe Pediatrics Medicine Market Size by Type (2015-2020)
7.4 Europe Pediatrics Medicine Market Size by Application (2015-2020)
8 CHINA
8.1 China Pediatrics Medicine Market Size (2015-2020)
8.2 Pediatrics Medicine Key Players in China (2019-2020)
8.3 China Pediatrics Medicine Market Size by Type (2015-2020)
8.4 China Pediatrics Medicine Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Pediatrics Medicine Market Size (2015-2020)
9.2 Pediatrics Medicine Key Players in Japan (2019-2020)
9.3 Japan Pediatrics Medicine Market Size by Type (2015-2020)
9.4 Japan Pediatrics Medicine Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Pediatrics Medicine Market Size (2015-2020)
10.2 Pediatrics Medicine Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pediatrics Medicine Market Size by Type (2015-2020)
10.4 Southeast Asia Pediatrics Medicine Market Size by Application (2015-2020)
11 INDIA
11.1 India Pediatrics Medicine Market Size (2015-2020)
11.2 Pediatrics Medicine Key Players in India (2019-2020)
11.3 India Pediatrics Medicine Market Size by Type (2015-2020)
11.4 India Pediatrics Medicine Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Pediatrics Medicine Market Size (2015-2020)
12.2 Pediatrics Medicine Key Players in Central & South America (2019-2020)
12.3 Central & South America Pediatrics Medicine Market Size by Type (2015-2020)
12.4 Central & South America Pediatrics Medicine Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 GSK
13.1.1 GSK Company Details
13.1.2 GSK Business Overview and Its Total Revenue
13.1.3 GSK Pediatrics Medicine Introduction
13.1.4 GSK Revenue in Pediatrics Medicine Business (2015-2020))
13.1.5 GSK Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview and Its Total Revenue
13.2.3 Novartis Pediatrics Medicine Introduction
13.2.4 Novartis Revenue in Pediatrics Medicine Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview and Its Total Revenue
13.3.3 Pfizer Pediatrics Medicine Introduction
13.3.4 Pfizer Revenue in Pediatrics Medicine Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Sanofi
13.4.1 Sanofi Company Details
13.4.2 Sanofi Business Overview and Its Total Revenue
13.4.3 Sanofi Pediatrics Medicine Introduction
13.4.4 Sanofi Revenue in Pediatrics Medicine Business (2015-2020)
13.4.5 Sanofi Recent Development
13.5 Abbott
13.5.1 Abbott Company Details
13.5.2 Abbott Business Overview and Its Total Revenue
13.5.3 Abbott Pediatrics Medicine Introduction
13.5.4 Abbott Revenue in Pediatrics Medicine Business (2015-2020)
13.5.5 Abbott Recent Development
13.6 Bristol-Myers Squibb
13.6.1 Bristol-Myers Squibb Company Details
13.6.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
13.6.3 Bristol-Myers Squibb Pediatrics Medicine Introduction
13.6.4 Bristol-Myers Squibb Revenue in Pediatrics Medicine Business (2015-2020)
13.6.5 Bristol-Myers Squibb Recent Development
13.7 Cipla
13.7.1 Cipla Company Details
13.7.2 Cipla Business Overview and Its Total Revenue
13.7.3 Cipla Pediatrics Medicine Introduction
13.7.4 Cipla Revenue in Pediatrics Medicine Business (2015-2020)
13.7.5 Cipla Recent Development
13.8 Eisai Pharmaceuticals
13.8.1 Eisai Pharmaceuticals Company Details
13.8.2 Eisai Pharmaceuticals Business Overview and Its Total Revenue
13.8.3 Eisai Pharmaceuticals Pediatrics Medicine Introduction
13.8.4 Eisai Pharmaceuticals Revenue in Pediatrics Medicine Business (2015-2020)
13.8.5 Eisai Pharmaceuticals Recent Development
13.9 Eli Lilly
13.9.1 Eli Lilly Company Details
13.9.2 Eli Lilly Business Overview and Its Total Revenue
13.9.3 Eli Lilly Pediatrics Medicine Introduction
13.9.4 Eli Lilly Revenue in Pediatrics Medicine Business (2015-2020)
13.9.5 Eli Lilly Recent Development
13.10 F. Hoffman-La Roche
13.10.1 F. Hoffman-La Roche Company Details
13.10.2 F. Hoffman-La Roche Business Overview and Its Total Revenue
13.10.3 F. Hoffman-La Roche Pediatrics Medicine Introduction
13.10.4 F. Hoffman-La Roche Revenue in Pediatrics Medicine Business (2015-2020)
13.10.5 F. Hoffman-La Roche Recent Development
13.11 Glenmark
10.11.1 Glenmark Company Details
10.11.2 Glenmark Business Overview and Its Total Revenue
10.11.3 Glenmark Pediatrics Medicine Introduction
10.11.4 Glenmark Revenue in Pediatrics Medicine Business (2015-2020)
10.11.5 Glenmark Recent Development
13.12 Helsinn Healthcare
10.12.1 Helsinn Healthcare Company Details
10.12.2 Helsinn Healthcare Business Overview and Its Total Revenue
10.12.3 Helsinn Healthcare Pediatrics Medicine Introduction
10.12.4 Helsinn Healthcare Revenue in Pediatrics Medicine Business (2015-2020)
10.12.5 Helsinn Healthcare Recent Development
13.13 Heron Therapeutics
10.13.1 Heron Therapeutics Company Details
10.13.2 Heron Therapeutics Business Overview and Its Total Revenue
10.13.3 Heron Therapeutics Pediatrics Medicine Introduction
10.13.4 Heron Therapeutics Revenue in Pediatrics Medicine Business (2015-2020)
10.13.5 Heron Therapeutics Recent Development
13.14 Ipca Laboratories
10.14.1 Ipca Laboratories Company Details
10.14.2 Ipca Laboratories Business Overview and Its Total Revenue
10.14.3 Ipca Laboratories Pediatrics Medicine Introduction
10.14.4 Ipca Laboratories Revenue in Pediatrics Medicine Business (2015-2020)
10.14.5 Ipca Laboratories Recent Development
13.15 Lupin Pharmaceuticals
10.15.1 Lupin Pharmaceuticals Company Details
10.15.2 Lupin Pharmaceuticals Business Overview and Its Total Revenue
10.15.3 Lupin Pharmaceuticals Pediatrics Medicine Introduction
10.15.4 Lupin Pharmaceuticals Revenue in Pediatrics Medicine Business (2015-2020)
10.15.5 Lupin Pharmaceuticals Recent Development
13.16 Merck Sharp & Dohme
10.16.1 Merck Sharp & Dohme Company Details
10.16.2 Merck Sharp & Dohme Business Overview and Its Total Revenue
10.16.3 Merck Sharp & Dohme Pediatrics Medicine Introduction
10.16.4 Merck Sharp & Dohme Revenue in Pediatrics Medicine Business (2015-2020)
10.16.5 Merck Sharp & Dohme Recent Development
13.17 RedHill
10.17.1 RedHill Company Details
10.17.2 RedHill Business Overview and Its Total Revenue
10.17.3 RedHill Pediatrics Medicine Introduction
10.17.4 RedHill Revenue in Pediatrics Medicine Business (2015-2020)
10.17.5 RedHill Recent Development
13.18 Sun Pharmaceutical Industries
10.18.1 Sun Pharmaceutical Industries Company Details
10.18.2 Sun Pharmaceutical Industries Business Overview and Its Total Revenue
10.18.3 Sun Pharmaceutical Industries Pediatrics Medicine Introduction
10.18.4 Sun Pharmaceutical Industries Revenue in Pediatrics Medicine Business (2015-2020)
10.18.5 Sun Pharmaceutical Industries Recent Development
13.19 Takeda Pharmaceutical
10.19.1 Takeda Pharmaceutical Company Details
10.19.2 Takeda Pharmaceutical Business Overview and Its Total Revenue
10.19.3 Takeda Pharmaceutical Pediatrics Medicine Introduction
10.19.4 Takeda Pharmaceutical Revenue in Pediatrics Medicine Business (2015-2020)
10.19.5 Takeda Pharmaceutical Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Pediatrics Medicine Key Market Segments
Table 2. Key Players Covered: Ranking by Pediatrics Medicine Revenue
Table 3. Ranking of Global Top Pediatrics Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pediatrics Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Enteral
Table 6. Key Players of Parenteral
Table 7. COVID-19 Impact Global Market: (Four Pediatrics Medicine Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Pediatrics Medicine Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Pediatrics Medicine Players to Combat Covid-19 Impact
Table 12. Global Pediatrics Medicine Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Pediatrics Medicine Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Pediatrics Medicine Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Pediatrics Medicine Market Share by Regions (2015-2020)
Table 16. Global Pediatrics Medicine Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Pediatrics Medicine Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Pediatrics Medicine Market Growth Strategy
Table 22. Main Points Interviewed from Key Pediatrics Medicine Players
Table 23. Global Pediatrics Medicine Revenue by Players (2015-2020) (Million US$)
Table 24. Global Pediatrics Medicine Market Share by Players (2015-2020)
Table 25. Global Top Pediatrics Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatrics Medicine as of 2019)
Table 26. Global Pediatrics Medicine by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Pediatrics Medicine Product Solution and Service
Table 29. Date of Enter into Pediatrics Medicine Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)
Table 32. Global Pediatrics Medicine Market Size Share by Type (2015-2020)
Table 33. Global Pediatrics Medicine Revenue Market Share by Type (2021-2026)
Table 34. Global Pediatrics Medicine Market Size Share by Application (2015-2020)
Table 35. Global Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)
Table 36. Global Pediatrics Medicine Market Size Share by Application (2021-2026)
Table 37. North America Key Players Pediatrics Medicine Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Pediatrics Medicine Market Share (2019-2020)
Table 39. North America Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)
Table 40. North America Pediatrics Medicine Market Share by Type (2015-2020)
Table 41. North America Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)
Table 42. North America Pediatrics Medicine Market Share by Application (2015-2020)
Table 43. Europe Key Players Pediatrics Medicine Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Pediatrics Medicine Market Share (2019-2020)
Table 45. Europe Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Pediatrics Medicine Market Share by Type (2015-2020)
Table 47. Europe Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Pediatrics Medicine Market Share by Application (2015-2020)
Table 49. China Key Players Pediatrics Medicine Revenue (2019-2020) (Million US$)
Table 50. China Key Players Pediatrics Medicine Market Share (2019-2020)
Table 51. China Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)
Table 52. China Pediatrics Medicine Market Share by Type (2015-2020)
Table 53. China Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)
Table 54. China Pediatrics Medicine Market Share by Application (2015-2020)
Table 55. Japan Key Players Pediatrics Medicine Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Pediatrics Medicine Market Share (2019-2020)
Table 57. Japan Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Pediatrics Medicine Market Share by Type (2015-2020)
Table 59. Japan Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Pediatrics Medicine Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Pediatrics Medicine Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Pediatrics Medicine Market Share (2019-2020)
Table 63. Southeast Asia Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Pediatrics Medicine Market Share by Type (2015-2020)
Table 65. Southeast Asia Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Pediatrics Medicine Market Share by Application (2015-2020)
Table 67. India Key Players Pediatrics Medicine Revenue (2019-2020) (Million US$)
Table 68. India Key Players Pediatrics Medicine Market Share (2019-2020)
Table 69. India Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)
Table 70. India Pediatrics Medicine Market Share by Type (2015-2020)
Table 71. India Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)
Table 72. India Pediatrics Medicine Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Pediatrics Medicine Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Pediatrics Medicine Market Share (2019-2020)
Table 75. Central & South America Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Pediatrics Medicine Market Share by Type (2015-2020)
Table 77. Central & South America Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Pediatrics Medicine Market Share by Application (2015-2020)
Table 79. GSK Company Details
Table 80. GSK Business Overview
Table 81. GSK Product
Table 82. GSK Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 83. GSK Recent Development
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Product
Table 87. Novartis Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 88. Novartis Recent Development
Table 89. Pfizer Company Details
Table 90. Pfizer Business Overview
Table 91. Pfizer Product
Table 92. Pfizer Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 93. Pfizer Recent Development
Table 94. Sanofi Company Details
Table 95. Sanofi Business Overview
Table 96. Sanofi Product
Table 97. Sanofi Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 98. Sanofi Recent Development
Table 99. Abbott Company Details
Table 100. Abbott Business Overview
Table 101. Abbott Product
Table 102. Abbott Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 103. Abbott Recent Development
Table 104. Bristol-Myers Squibb Company Details
Table 105. Bristol-Myers Squibb Business Overview
Table 106. Bristol-Myers Squibb Product
Table 107. Bristol-Myers Squibb Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 108. Bristol-Myers Squibb Recent Development
Table 109. Cipla Company Details
Table 110. Cipla Business Overview
Table 111. Cipla Product
Table 112. Cipla Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 113. Cipla Recent Development
Table 114. Eisai Pharmaceuticals Business Overview
Table 115. Eisai Pharmaceuticals Product
Table 116. Eisai Pharmaceuticals Company Details
Table 117. Eisai Pharmaceuticals Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 118. Eisai Pharmaceuticals Recent Development
Table 119. Eli Lilly Company Details
Table 120. Eli Lilly Business Overview
Table 121. Eli Lilly Product
Table 122. Eli Lilly Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 123. Eli Lilly Recent Development
Table 124. F. Hoffman-La Roche Company Details
Table 125. F. Hoffman-La Roche Business Overview
Table 126. F. Hoffman-La Roche Product
Table 127. F. Hoffman-La Roche Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 128. F. Hoffman-La Roche Recent Development
Table 129. Glenmark Company Details
Table 130. Glenmark Business Overview
Table 131. Glenmark Product
Table 132. Glenmark Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 133. Glenmark Recent Development
Table 134. Helsinn Healthcare Company Details
Table 135. Helsinn Healthcare Business Overview
Table 136. Helsinn Healthcare Product
Table 137. Helsinn Healthcare Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 138. Helsinn Healthcare Recent Development
Table 139. Heron Therapeutics Company Details
Table 140. Heron Therapeutics Business Overview
Table 141. Heron Therapeutics Product
Table 142. Heron Therapeutics Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 143. Heron Therapeutics Recent Development
Table 144. Ipca Laboratories Company Details
Table 145. Ipca Laboratories Business Overview
Table 146. Ipca Laboratories Product
Table 147. Ipca Laboratories Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 148. Ipca Laboratories Recent Development
Table 149. Lupin Pharmaceuticals Company Details
Table 150. Lupin Pharmaceuticals Business Overview
Table 151. Lupin Pharmaceuticals Product
Table 152. Lupin Pharmaceuticals Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 153. Lupin Pharmaceuticals Recent Development
Table 154. Merck Sharp & Dohme Company Details
Table 155. Merck Sharp & Dohme Business Overview
Table 156. Merck Sharp & Dohme Product
Table 157. Merck Sharp & Dohme Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 158. Merck Sharp & Dohme Recent Development
Table 159. RedHill Company Details
Table 160. RedHill Business Overview
Table 161. RedHill Product
Table 162. RedHill Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 163. RedHill Recent Development
Table 164. Sun Pharmaceutical Industries Company Details
Table 165. Sun Pharmaceutical Industries Business Overview
Table 166. Sun Pharmaceutical Industries Product
Table 167. Sun Pharmaceutical Industries Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 168. Sun Pharmaceutical Industries Recent Development
Table 169. Takeda Pharmaceutical Company Details
Table 170. Takeda Pharmaceutical Business Overview
Table 171. Takeda Pharmaceutical Product
Table 172. Takeda Pharmaceutical Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 173. Takeda Pharmaceutical Recent Development
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
Table 1. Pediatrics Medicine Key Market Segments
Table 2. Key Players Covered: Ranking by Pediatrics Medicine Revenue
Table 3. Ranking of Global Top Pediatrics Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pediatrics Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Enteral
Table 6. Key Players of Parenteral
Table 7. COVID-19 Impact Global Market: (Four Pediatrics Medicine Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Pediatrics Medicine Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Pediatrics Medicine Players to Combat Covid-19 Impact
Table 12. Global Pediatrics Medicine Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Pediatrics Medicine Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Pediatrics Medicine Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Pediatrics Medicine Market Share by Regions (2015-2020)
Table 16. Global Pediatrics Medicine Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Pediatrics Medicine Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Pediatrics Medicine Market Growth Strategy
Table 22. Main Points Interviewed from Key Pediatrics Medicine Players
Table 23. Global Pediatrics Medicine Revenue by Players (2015-2020) (Million US$)
Table 24. Global Pediatrics Medicine Market Share by Players (2015-2020)
Table 25. Global Top Pediatrics Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatrics Medicine as of 2019)
Table 26. Global Pediatrics Medicine by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Pediatrics Medicine Product Solution and Service
Table 29. Date of Enter into Pediatrics Medicine Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)
Table 32. Global Pediatrics Medicine Market Size Share by Type (2015-2020)
Table 33. Global Pediatrics Medicine Revenue Market Share by Type (2021-2026)
Table 34. Global Pediatrics Medicine Market Size Share by Application (2015-2020)
Table 35. Global Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)
Table 36. Global Pediatrics Medicine Market Size Share by Application (2021-2026)
Table 37. North America Key Players Pediatrics Medicine Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Pediatrics Medicine Market Share (2019-2020)
Table 39. North America Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)
Table 40. North America Pediatrics Medicine Market Share by Type (2015-2020)
Table 41. North America Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)
Table 42. North America Pediatrics Medicine Market Share by Application (2015-2020)
Table 43. Europe Key Players Pediatrics Medicine Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Pediatrics Medicine Market Share (2019-2020)
Table 45. Europe Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Pediatrics Medicine Market Share by Type (2015-2020)
Table 47. Europe Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Pediatrics Medicine Market Share by Application (2015-2020)
Table 49. China Key Players Pediatrics Medicine Revenue (2019-2020) (Million US$)
Table 50. China Key Players Pediatrics Medicine Market Share (2019-2020)
Table 51. China Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)
Table 52. China Pediatrics Medicine Market Share by Type (2015-2020)
Table 53. China Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)
Table 54. China Pediatrics Medicine Market Share by Application (2015-2020)
Table 55. Japan Key Players Pediatrics Medicine Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Pediatrics Medicine Market Share (2019-2020)
Table 57. Japan Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Pediatrics Medicine Market Share by Type (2015-2020)
Table 59. Japan Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Pediatrics Medicine Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Pediatrics Medicine Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Pediatrics Medicine Market Share (2019-2020)
Table 63. Southeast Asia Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Pediatrics Medicine Market Share by Type (2015-2020)
Table 65. Southeast Asia Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Pediatrics Medicine Market Share by Application (2015-2020)
Table 67. India Key Players Pediatrics Medicine Revenue (2019-2020) (Million US$)
Table 68. India Key Players Pediatrics Medicine Market Share (2019-2020)
Table 69. India Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)
Table 70. India Pediatrics Medicine Market Share by Type (2015-2020)
Table 71. India Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)
Table 72. India Pediatrics Medicine Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Pediatrics Medicine Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Pediatrics Medicine Market Share (2019-2020)
Table 75. Central & South America Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Pediatrics Medicine Market Share by Type (2015-2020)
Table 77. Central & South America Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Pediatrics Medicine Market Share by Application (2015-2020)
Table 79. GSK Company Details
Table 80. GSK Business Overview
Table 81. GSK Product
Table 82. GSK Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 83. GSK Recent Development
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Product
Table 87. Novartis Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 88. Novartis Recent Development
Table 89. Pfizer Company Details
Table 90. Pfizer Business Overview
Table 91. Pfizer Product
Table 92. Pfizer Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 93. Pfizer Recent Development
Table 94. Sanofi Company Details
Table 95. Sanofi Business Overview
Table 96. Sanofi Product
Table 97. Sanofi Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 98. Sanofi Recent Development
Table 99. Abbott Company Details
Table 100. Abbott Business Overview
Table 101. Abbott Product
Table 102. Abbott Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 103. Abbott Recent Development
Table 104. Bristol-Myers Squibb Company Details
Table 105. Bristol-Myers Squibb Business Overview
Table 106. Bristol-Myers Squibb Product
Table 107. Bristol-Myers Squibb Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 108. Bristol-Myers Squibb Recent Development
Table 109. Cipla Company Details
Table 110. Cipla Business Overview
Table 111. Cipla Product
Table 112. Cipla Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 113. Cipla Recent Development
Table 114. Eisai Pharmaceuticals Business Overview
Table 115. Eisai Pharmaceuticals Product
Table 116. Eisai Pharmaceuticals Company Details
Table 117. Eisai Pharmaceuticals Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 118. Eisai Pharmaceuticals Recent Development
Table 119. Eli Lilly Company Details
Table 120. Eli Lilly Business Overview
Table 121. Eli Lilly Product
Table 122. Eli Lilly Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 123. Eli Lilly Recent Development
Table 124. F. Hoffman-La Roche Company Details
Table 125. F. Hoffman-La Roche Business Overview
Table 126. F. Hoffman-La Roche Product
Table 127. F. Hoffman-La Roche Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 128. F. Hoffman-La Roche Recent Development
Table 129. Glenmark Company Details
Table 130. Glenmark Business Overview
Table 131. Glenmark Product
Table 132. Glenmark Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 133. Glenmark Recent Development
Table 134. Helsinn Healthcare Company Details
Table 135. Helsinn Healthcare Business Overview
Table 136. Helsinn Healthcare Product
Table 137. Helsinn Healthcare Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 138. Helsinn Healthcare Recent Development
Table 139. Heron Therapeutics Company Details
Table 140. Heron Therapeutics Business Overview
Table 141. Heron Therapeutics Product
Table 142. Heron Therapeutics Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 143. Heron Therapeutics Recent Development
Table 144. Ipca Laboratories Company Details
Table 145. Ipca Laboratories Business Overview
Table 146. Ipca Laboratories Product
Table 147. Ipca Laboratories Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 148. Ipca Laboratories Recent Development
Table 149. Lupin Pharmaceuticals Company Details
Table 150. Lupin Pharmaceuticals Business Overview
Table 151. Lupin Pharmaceuticals Product
Table 152. Lupin Pharmaceuticals Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 153. Lupin Pharmaceuticals Recent Development
Table 154. Merck Sharp & Dohme Company Details
Table 155. Merck Sharp & Dohme Business Overview
Table 156. Merck Sharp & Dohme Product
Table 157. Merck Sharp & Dohme Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 158. Merck Sharp & Dohme Recent Development
Table 159. RedHill Company Details
Table 160. RedHill Business Overview
Table 161. RedHill Product
Table 162. RedHill Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 163. RedHill Recent Development
Table 164. Sun Pharmaceutical Industries Company Details
Table 165. Sun Pharmaceutical Industries Business Overview
Table 166. Sun Pharmaceutical Industries Product
Table 167. Sun Pharmaceutical Industries Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 168. Sun Pharmaceutical Industries Recent Development
Table 169. Takeda Pharmaceutical Company Details
Table 170. Takeda Pharmaceutical Business Overview
Table 171. Takeda Pharmaceutical Product
Table 172. Takeda Pharmaceutical Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)
Table 173. Takeda Pharmaceutical Recent Development
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Pediatrics Medicine Market Share by Type: 2020 VS 2026
Figure 2. Enteral Features
Figure 3. Parenteral Features
Figure 4. Global Pediatrics Medicine Market Share by Application: 2020 VS 2026
Figure 5. Respiratory diseases Case Studies
Figure 6. Infectious diseases Case Studies
Figure 7. Gastrointestinal diseases Case Studies
Figure 8. CNS diseases Case Studies
Figure 9. Oncological diseases Case Studies
Figure 10. CVDs Case Studies
Figure 11. Others Case Studies
Figure 12. Pediatrics Medicine Report Years Considered
Figure 13. Global Pediatrics Medicine Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Pediatrics Medicine Market Share by Regions: 2020 VS 2026
Figure 15. Global Pediatrics Medicine Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Pediatrics Medicine Market Share by Players in 2019
Figure 18. Global Top Pediatrics Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatrics Medicine as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Pediatrics Medicine Revenue in 2019
Figure 20. North America Pediatrics Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Pediatrics Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Pediatrics Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Pediatrics Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Pediatrics Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Pediatrics Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Pediatrics Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. GSK Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 29. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Novartis Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 31. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Pfizer Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 33. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Sanofi Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 35. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Abbott Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 37. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Bristol-Myers Squibb Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 39. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Cipla Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 41. Eisai Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Eisai Pharmaceuticals Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 43. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Eli Lilly Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 45. F. Hoffman-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. F. Hoffman-La Roche Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 47. Glenmark Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Glenmark Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 49. Helsinn Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Helsinn Healthcare Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 51. Heron Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Heron Therapeutics Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 53. Ipca Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Ipca Laboratories Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 55. Lupin Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Lupin Pharmaceuticals Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 57. Merck Sharp & Dohme Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Merck Sharp & Dohme Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 59. RedHill Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. RedHill Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 61. Sun Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Sun Pharmaceutical Industries Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 63. Takeda Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Takeda Pharmaceutical Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Figure 1. Global Pediatrics Medicine Market Share by Type: 2020 VS 2026
Figure 2. Enteral Features
Figure 3. Parenteral Features
Figure 4. Global Pediatrics Medicine Market Share by Application: 2020 VS 2026
Figure 5. Respiratory diseases Case Studies
Figure 6. Infectious diseases Case Studies
Figure 7. Gastrointestinal diseases Case Studies
Figure 8. CNS diseases Case Studies
Figure 9. Oncological diseases Case Studies
Figure 10. CVDs Case Studies
Figure 11. Others Case Studies
Figure 12. Pediatrics Medicine Report Years Considered
Figure 13. Global Pediatrics Medicine Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Pediatrics Medicine Market Share by Regions: 2020 VS 2026
Figure 15. Global Pediatrics Medicine Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Pediatrics Medicine Market Share by Players in 2019
Figure 18. Global Top Pediatrics Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatrics Medicine as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Pediatrics Medicine Revenue in 2019
Figure 20. North America Pediatrics Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Pediatrics Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Pediatrics Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Pediatrics Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Pediatrics Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Pediatrics Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Pediatrics Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. GSK Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 29. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Novartis Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 31. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Pfizer Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 33. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Sanofi Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 35. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Abbott Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 37. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Bristol-Myers Squibb Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 39. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Cipla Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 41. Eisai Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Eisai Pharmaceuticals Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 43. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Eli Lilly Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 45. F. Hoffman-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. F. Hoffman-La Roche Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 47. Glenmark Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Glenmark Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 49. Helsinn Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Helsinn Healthcare Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 51. Heron Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Heron Therapeutics Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 53. Ipca Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Ipca Laboratories Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 55. Lupin Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Lupin Pharmaceuticals Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 57. Merck Sharp & Dohme Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Merck Sharp & Dohme Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 59. RedHill Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. RedHill Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 61. Sun Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Sun Pharmaceutical Industries Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 63. Takeda Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Takeda Pharmaceutical Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed